跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Aepanpraz - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Aepanpraz
Approved
STANDARD
Aepanpraz
Yangtze River Pharmaceutical (Group) Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
52510590eabf8676
Company
Yangtze River Pharmaceutical (Group) Co., Ltd.
Type
Standard
Approval Details
Approval Id
52510590eabf8676
Drug Approval Philippines Name
Aepanpraz
Product Name
Aepanpraz
Registration Number
DR-XY45460
Brand Name
Aepanpraz
Generic Name
Pantoprazole ( As Sodium )
Dosage Form
Powder for Solution for Injection (IV)
Dosage Strength
40 mg
Manufacturer
Yangtze River Pharmaceutical (Group) Co., Ltd.
Trader
Kwan Star Co., Ltd.
Importer
Kwanstar Pharma Distributor
Distributor
Dynasty Pharmaceuticals
Company Detail Path
/organization/yangtze-river-pharmaceutical-group-co-ltd
Issuance Date
05 March 2021
Expiry Date
04 July 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
52510590eabf8676
Type
Standard
Back to Philippines FDA Approvals